(Q35132188)

6 August 2017

1 reference

title

Assessing abuse liability in clinical trials (English)

1 reference

6 August 2017

Kathleen T Brady

1

1 reference

6 August 2017

R Bruce Lydiard

series ordinal

2

1 reference

6 August 2017

Joseph V Brady

series ordinal

3

1 reference

6 August 2017

publication date

1 June 2003

1 reference

Drug and Alcohol Dependence

6 August 2017

published in

1 reference

6 August 2017

volume

70

1 reference

6 August 2017

issue

3 Suppl

1 reference

6 August 2017

page(s)

S87-95

1 reference

Postmarketing surveillance for drug abuse

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900101-7

7 January 2021

Principles of drug abuse liability assessment in laboratory animals

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900101-7

7 January 2021

Guidelines and methodological reviews concerning drug abuse liability assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900101-7

7 January 2021

Double-blind evaluation of reinforcing and anorectic actions of weight control medications. Interaction of pharmacological and behavioral treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900101-7

7 January 2021

A postmarketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900101-7

7 January 2021

Principles of initial experimental drug abuse liability assessment in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900101-7

7 January 2021

The pharmacokinetic principles behind scaling from preclinical results to phase I protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900101-7

7 January 2021

Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900101-7

7 January 2021

A novel Bayesian decision procedure for early-phase dose-finding studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900101-7

7 January 2021

Development of Optimal Treatment Tactics for Alcohol Withdrawal. I. Assessment and Effectiveness of Supportive Care

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900101-7

7 January 2021

Stopping rules for phase II studies

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900101-7

7 January 2021

10.1016/S0376-8716(03)00101-7

Identifiers

DOI

1 reference

6 August 2017

1 reference